HALO logo
halo search icon
BFK
Pharmesis International Ltd.

BFK · Pharmesis International Ltd.

0.14

SGD
0.00 (0.00%)
24/07/2026 12:00:00 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

S$4.34M

PE

0.00

EV/EBITDA

N/A

DIV Yield

0%

Payout Ratio

0%

MQV Rating

5Very Weak

As at 24/07/2026 12:00:00 AM

Price Chart

Description

Pharmesis International Ltd. is an investment holding company, which engages in the research, development, production, sale, and marketing of medicine and medicine formulated products for the treatment of illnesses relating to the liver and gall bladder. It operates through the following segments: Western Drugs, Traditional Chinese Medicine Formulated Drugs, and Distribution. The Western Drugs segment involves in the chemically formulated drugs and is marketed under the Kinna brand. The Traditional Chinese Medicine Formulated Drugs segment offers traditional Chinese medicine and is marketed under the Longlife brand. The Distribution segment includes agency products and internally manufactured products which are marketed through the distribution arm. The company was founded in 1996 and is headquartered in Singapore.

  • All-Companies
  • HALO All
  • Near 52 Week Low
  • Near Support

Key Fundamentals

EPS 3 yr Growth

-22.10%

EBITDA Margin

-5.50%

Operating Cashflow

$0m

Free Cash Flow Return

3.40%

ROIC

-7.10%

Interest Coverage

-3.50

Quick Ratio

0.60

Performance

52 weeks range

Low 0.13 - 0.45

Trade Value (12mth)

US$98.00

1 week

-62.47%

1 month

-60.86%

YTD

-58.48%

1 year

-16.97%

All time high

3.80

Additional Data

Shares Outstanding (Fully Diluted)

32m

HALO Sector

Healthcare

Next Company Report Date

N/A

Next Ex Dividend Date

20-Jul-26

Next Dividend Pay Date

31-Jul-26

Reporting Currency

SGD

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Pharmesis International Ltd. (BFK:SES)?
Halo FAQ
The current share price of Pharmesis International Ltd. (BFK:SES) is SGD$0.14.
2
What is the 52-week high share price for Pharmesis International Ltd. (BFK:SES)?
Halo FAQ
The 52-week high share price for Pharmesis International Ltd. (BFK:SES) is SGD$0.45.
3
What is the 52-week low share price for Pharmesis International Ltd. (BFK:SES)?
Halo FAQ
The 52-week low share price for Pharmesis International Ltd. (BFK:SES) is SGD$0.13.
4
What is the dividend yield for Pharmesis International Ltd. (BFK:SES)?
Halo FAQ
Pharmesis International Ltd. (BFK:SES) does not pay a dividend.
5
What was Pharmesis International Ltd. (BFK:SES) last dividend payment?
Halo FAQ
Pharmesis International Ltd. (BFK:SES) does not pay a dividend.
6
What is the franking level for Pharmesis International Ltd. (BFK:SES)?
Halo FAQ
Pharmesis International Ltd. (BFK:SES) has a franking level of 0.00%.
7
In which sector is Pharmesis International Ltd. (BFK:SES) classified?
Halo FAQ
Pharmesis International Ltd. (BFK:SES) is classified in the Healthcare.